Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SPIRIVA RESPIMAT
- Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma
- Tiotropium vs. Inhaled Corticosteroids in Children With Nonatopic Asthma Pilot Study (TioNAAP)
- Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
- PIFR-based Inhalation Therapy in Patients Recovering From AECOPD
- A Study on Whether Patients Prefer the Spiriva® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)
- Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease
- Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma
- Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma
- Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers
- Efficacy of Intermittent Tiotropium in Early Childhood Wheezing
- Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With A Reference Product
- Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Description of the Ability to Learn How to Handle Inhaler Devices in COPD
- Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference Products
- Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products
- Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMA
- Specific Use-result Surveillance of Spiriva Respimat in Asthmatics
- 24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and Placebo
- Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy
- To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®
- Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®
- Tiotropium Bromide in Cystic Fibrosis
- Interaction in Chronic Obstructive Pulmonary Disease Experiment
- A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)
- Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD
Clinical trials list
click for details